研究成果を検索

検索結果

• 2019

  IJU this issue

  Eto, M., 6 1 2019, In: International journal of urology : official journal of the Japanese Urological Association. 26, 6, p. 595 1 p.

  研究成果: Contribution to journal › Article › 査読

  Open Access

• Immune suppression by PD-L2 against spontaneous and treatment-related antitumor immunity

  Tanegashima, T., Togashi, Y., Azuma, K., Kawahara, A., Ideguchi, K., Sugiyama, D., Kinoshita, F., Akiba, J., Kashiwagi, E., Takeuchi, A., Irie, T., Tatsugami, K., Hoshino, T., Eto, M. & Nishikawa, H., 8 1 2019, In: Clinical Cancer Research. 25, 15, p. 4808-4819 12 p.

  研究成果: Contribution to journal › Article › 査読

  • Immunity
  • Animal Models
  • Neoplasms
  • Renal Cell Carcinoma
  • Squamous Cell Carcinoma
  12 被引用数 (Scopus)

• Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

  JCOG UOSG, 12 1 2019, In: The Journal of urology. 202, 6, p. 1127-1135 9 p.

  研究成果: Contribution to journal › Article › 査読

  • Nephroureterectomy
  • Urinary Tract
  • Urinary Bladder Neoplasms
  • Carcinoma
  • Survival
  5 被引用数 (Scopus)

• Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment

  Umezu, D., Okada, N., Sakoda, Y., Adachi, K., Ojima, T., Yamaue, H., Eto, M. & Tamada, K., 2 13 2019, In: Cancer Immunology, Immunotherapy. 68, 2, p. 201-211 11 p.

  研究成果: Contribution to journal › Article › 査読

  • Tumor Microenvironment
  • Immunity
  • Monoclonal Antibodies
  • Neoplasms
  • Programmed Cell Death 1 Ligand 2 Protein
  15 被引用数 (Scopus)

• Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: Study design and rationale

  Grünwald, V., Powles, T., Choueiri, T. K., Hutson, T. E., Porta, C., Eto, M., Sternberg, C. N., Rha, S. Y., He, C. S., Dutcus, C. E., Smith, A., Dutta, L., Mody, K. & Motzer, R. J., 3 2019, In: Future Oncology. 15, 9, p. 929-941 13 p.

  研究成果: Contribution to journal › Article › 査読

  Open Access

  • lenvatinib
  • pembrolizumab
  • Sunitinib
  • Everolimus
  • Renal Cell Carcinoma
  13 被引用数 (Scopus)

• MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma

  Kurahashi, R., Kadomatsu, T., Baba, M., Hara, C., Itoh, H., Miyata, K., Endo, M., Morinaga, J., Terada, K., Araki, K., Eto, M., Schmidt, L. S., Kamba, T., Linehan, W. M. & Oike, Y., 6 2019, In: Cancer Science. 110, 6, p. 1897-1908 12 p.

  研究成果: Contribution to journal › Article › 査読

  Open Access

  • Renal Cell Carcinoma
  • MicroRNAs
  • Exosomes
  • Biomarkers
  • Transgenic Mice
  11 被引用数 (Scopus)

• Mirabegron induces relaxant effects via cAMP signaling-dependent and -independent pathways in detrusor smooth muscle

  Maki, T., Kajioka, S., Itsumi, M., Kareman, E., Lee, K., Shiota, M. & Eto, M., 4 2019, In: LUTS: Lower Urinary Tract Symptoms. 11, 2, p. O209-O217

  研究成果: Contribution to journal › Article › 査読

  • mirabegron
  • Smooth Muscle
  • Swine
  • Carbachol
  • Escin
  3 被引用数 (Scopus)

• Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses

  Ohyama, C., Kojima, T., Kondo, T., Naya, Y., Inoue, T., Tomita, Y., Eto, M., Hisasue, S., Uemura, H., Obara, W., Kikuchi, E., Sharma, P., Galsky, M. D., Siefker-Radtke, A., Grossfeld, G., Collette, S., Gooden, K. & Kimura, G., 9 13 2019, In: International Journal of Clinical Oncology. 24, 9, p. 1089-1098 10 p.

  研究成果: Contribution to journal › Article › 査読

  • Nivolumab
  • Carcinoma
  • Advisory Committees
  • Population
  • Confidence Intervals
  5 被引用数 (Scopus)

• Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study

  Tomita, Y., Fukasawa, S., Shinohara, N., Kitamura, H., Oya, M., Eto, M., Tanabe, K., Saito, M., Kimura, G., Yonese, J., Yao, M. & Uemura, H., 5 29 2019, In: Japanese journal of clinical oncology. 49, 6, p. 506-514 9 p.

  研究成果: Contribution to journal › Article › 査読

  • Nivolumab
  • Everolimus
  • Renal Cell Carcinoma
  • Population
  • Confidence Intervals
  15 被引用数 (Scopus)

• Overview of current and future systemic therapy for metastatic renal cell carcinoma

  Osawa, T., Takeuchi, A., Kojima, T., Shinohara, N., Eto, M. & Nishiyama, H., 2019, In: Japanese journal of clinical oncology. 49, 5, p. 395-403 9 p.

  研究成果: Contribution to journal › Article › 査読

  • Renal Cell Carcinoma
  • Vascular Endothelial Growth Factor A
  • Nivolumab
  • TOR Serine-Threonine Kinases
  • lenvatinib
  11 被引用数 (Scopus)

• Papillary renal cell carcinoma with massive hematoma mimicking hemangioma

  Hiraki, Y., Okamoto, D., Nishie, A., Asayama, Y., Ishigami, K., Ushijima, Y., Takayama, Y., Fujita, N., Eto, M., Kinoshita, F. & Honda, H., 8 2019, In: Radiology Case Reports. 14, 8, p. 1003-1006 4 p.

  研究成果: Contribution to journal › Article › 査読

  Open Access

  • Hemangioma
  • Renal Cell Carcinoma
  • Hematoma
  • Hemorrhage
  • Tomography
  1 被引用数 (Scopus)

• Partial nephrectomy for renal tumors

  Tatsugami, K. & Eto, M., 8 2019, In: Nishinihon Journal of Urology. 81, 4, p. 435-439 5 p.

  研究成果: Contribution to journal › Review article › 査読

  • Nephrectomy
  • Kidney
  • Neoplasms
  • Nephrons
  • Margins of Excision

• Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: Analysis of a nation-wide registry program

  Kume, H., Homma, Y., Shinohara, N., Obara, W., Kondo, T., Kimura, G., Fujimoto, H., Nonomura, N., Hongo, F., Sugiyama, T., Takahashi, M., Kanayama, H. O., Fukumori, T. & Eto, M., 8 1 2019, In: Japanese journal of clinical oncology. 49, 8, p. 772-779 8 p.

  研究成果: Contribution to journal › Article › 査読

  Open Access

  • Renal Cell Carcinoma
  • Registries
  • Fats
  • Multivariate Analysis
  • Cohort Studies
  1 被引用数 (Scopus)

• Predictive factors for residual cancer in second transurethral resection for non-muscle-invasive bladder cancer

  Akitake, M., Yamaguchi, A., Shiota, M., Imada, K., Tatsugami, K., Yokomizo, A., Naito, S. & Eto, M., 2019, In: Anticancer research. 39, 8, p. 4325-4328 4 p.

  研究成果: Contribution to journal › Article › 査読

  • Residual Neoplasm
  • Urinary Bladder Neoplasms
  • Carcinoma in Situ
  • Neoplasm Staging
  2 被引用数 (Scopus)

• Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma

  Inokuchi, J. & Eto, M., 2019, In: Cancer Management and Research. 11, p. 4519-4528 10 p.

  研究成果: Contribution to journal › Article › 査読

  Open Access

  • pembrolizumab
  • Carcinoma
  • Drug Therapy
  • atezolizumab
  • Platinum
  2 被引用数 (Scopus)

• Prognostic significance of antihypertensive agents in men with castration-resistant prostate cancer

  Shiota, M., Kobayashi, T., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K. & Eto, M., 11 2019, In: Urologic Oncology: Seminars and Original Investigations. 37, 11, p. 813.e21-813.e26

  研究成果: Contribution to journal › Article › 査読

  • Castration
  • Antihypertensive Agents
  • Docetaxel
  • Androgen Receptors
  • Prostatic Neoplasms

• Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer

  Hirata, Y., Shiota, M., Kobayashi, T., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K. & Eto, M., 12 2019, In: Prostate International. 7, 4, p. 166-170 5 p.

  研究成果: Contribution to journal › Article › 査読

  Open Access

  • Dyslipidemias
  • Androgens
  • Diabetes Mellitus
  • Prostatic Neoplasms
  • Metabolic Diseases
  1 被引用数 (Scopus)

• Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer

  Shiota, M., Namitome, R., Kobayashi, T., Inokuchi, J., Tatsugami, K. & Eto, M., 3 2019, In: International Journal of Urology. 26, 3, p. 426-428 3 p.

  研究成果: Contribution to journal › Comment/debate › 査読
  10 被引用数 (Scopus)

• Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancer

  Kashiwagi, E., Imada, K., Monji, K., Takeuchi, A., Shiota, M., Inokuchi, J., Tatsugami, K. & Eto, M., 10 1 2019, In: Andrologia. 51, 9, e13354.

  研究成果: Contribution to journal › Article › 査読

  • Psoas Muscles
  • Erectile Dysfunction
  • Sexual Behavior
  • Prostatic Neoplasms
  • Body Composition

• Reconstitution of the embryonic kidney identifies a donor cell contribution to the renal vasculature upon transplantation

  Murakami, Y., Naganuma, H., Tanigawa, S., Fujimori, T., Eto, M. & Nishinakamura, R., 12 1 2019, In: Scientific reports. 9, 1, 1172.

  研究成果: Contribution to journal › Article › 査読

  Open Access

  • Transplantation
  • Kidney
  • Endothelial Cells
  • Pluripotent Stem Cells
  • Blood Vessels
  3 被引用数 (Scopus)

• Serum Prognostic Factors of Androgen-deprivation Therapy among Japanese Men with De Novo Metastatic Prostate Cancer

  Kobayashi, T., Namitome, R., Hirata, Y., Shiota, M., Imada, K., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K. & Eto, M., 2019, In: Anticancer research. 39, 6, p. 3191-3195 5 p.

  研究成果: Contribution to journal › Article › 査読

  • Androgens
  • Prostatic Neoplasms
  • L-Lactate Dehydrogenase
  • Confidence Intervals
  • Alkaline Phosphatase
  1 被引用数 (Scopus)

• Serum testosterone level as possible predictive marker in androgen receptor axis-targeting agents and taxane chemotherapies for castration-resistant prostate cancer

  Shiota, M., Kashiwagi, E., Murakami, T., Takeuchi, A., Imada, K., Inokuchi, J., Tatsugami, K. & Eto, M., 3 2019, In: Urologic Oncology: Seminars and Original Investigations. 37, 3, p. 180.e19-180.e24

  研究成果: Contribution to journal › Article › 査読

  • taxane
  • Castration
  • Androgen Receptors
  • Testosterone
  • Prostatic Neoplasms
  7 被引用数 (Scopus)

• TFE3 XP11.2 translocation renal cell carcinoma mouse model reveals novel therapeutic targets and identifies GPNMB as a diagnostic marker for human disease

  Baba, M., Furuya, M., Motoshima, T., Lang, M., Funasaki, S., Ma, W., Sun, H. W., Hasumi, H., Huang, Y., Kato, I., Kadomatsu, T., Satou, Y., Morris, N., Karim, B. O., Ileva, L., Kalen, J. D., Krisna, L. A. W., Hasumi, Y., Sugiyama, A., Kurahashi, R. & 12 others, Nishimoto, K., Oyama, M., Nagashima, Y., Kuroda, N., Araki, K., Eto, M., Yao, M., Kamba, T., Suda, T., Oike, Y., Schmidt, L. S. & Marston Linehan, W., 8 1 2019, In: Molecular Cancer Research. 17, 8, p. 1613-1626 14 p.

  研究成果: Contribution to journal › Article › 査読

  Open Access

  • Renal Cell Carcinoma
  • Therapeutics
  • Biomarkers
  • Kidney
  • N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
  4 被引用数 (Scopus)

• The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men

  Shiota, M., Fujimoto, N., Tsukahara, S., Ushijima, M., Takeuchi, A., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Uchiumi, T. & Eto, M., 1 1 2019, In: Cancer chemotherapy and pharmacology.

  研究成果: Contribution to journal › Article › 査読

  • Polymorphism
  • Genetic Polymorphisms
  • Androgens
  • Testosterone
  • Genes
  3 被引用数 (Scopus)

• Therapeutic outcome of >10 cycles of cabazitaxel for castration-resistant prostate cancer: A Multi-institutional Study

  Shiota, M., Nakamura, M., Yokomizo, A., Tomoda, T., Sakamoto, N., Seki, N., Hasegawa, S., Yunoki, T., Harano, M., Kuroiwa, K. & Eto, M., 2019, In: Anticancer research. 39, 8, p. 4411-4414 4 p.

  研究成果: Contribution to journal › Article › 査読

  • cabazitaxel
  • Castration
  • Prostatic Neoplasms
  • Survival
  • Treatment Failure

• Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan

  Harada, K., Nozawa, M., Uemura, M., Tatsugami, K., Osawa, T., Yamana, K., Kimura, G., Fujisawa, M., Nonomura, N., Eto, M., Shinohara, N., Tomita, Y., Kondo, Y., Ochi, K., Anazawa, Y. & Uemura, H., 2 1 2019, In: International Journal of Urology. 26, 2, p. 202-210 9 p.

  研究成果: Contribution to journal › Article › 査読

  • Renal Cell Carcinoma
  • Japan
  • Protein-Tyrosine Kinases
  • Phosphotransferases
  • Survival
  11 被引用数 (Scopus)